Gilead Sciences GmbH

Biotechnology, Chemical Industry

  • Short facts

    • Manufacturer
  • Year founded 1991
  • 66 Employees (site)
  • Turnover: <5m EUR

Products/services: Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases worldwide. Established in 1991, Gilead's Munich office provides medical, sales and marketing support in Germany. The German team is committed to offering and maintaining high-quality service to the medical community and is focused on the distribution of the company's products.

Basic data


Gilead Sciences GmbH


Fraunhoferstr. 17

PC / City

82152 Planegg


Upper Bavaria


+49 89 89989-00


+49 89 89989-090

Language skills

English, German


Core competencies

Gilead Sciences is dedicated to providing accelerated solutions for patients and the people who care for them. The evolution of Gilead - from a promising biopharmaceutical company to a leader in the international development and commercialisation of medicines for life-threatening infectious diseases (viral, fungal and bacterial infections) - is testament to what the company has achieved through disciplined science, visionary thinking and diversified planning. Gileads headquarter is based in Foster City, California with additional operations in San Dimas, California. Gilead maintains research, development and manufacturing facilities in the United States and Europe. Sales and marketing organisations are located in the following cities: Athens, Greece; Cambridge, UK; Lisbon, Portugal; Madrid, Spain; Melbourne, Australia; Milan, Italy; Munich, Germany and Paris, France.

Key sectors / sub-sectors

  • Biotechnology: Technical services for biotechnology
  • Biotechnology: Therapeutic drug development
  • Chemical Industry: Pharmaceutical preparations

NACE industries

  • Manufacture of basic pharmaceutical products and pharmaceutical preparations 21


not available

Sales markets - target industries

not available

Sales markets - target countries

not available

Cooperation offers

not available